DM PART 2 OF PART 1 Flashcards

1
Q

initial management of T2DM?

A

dietary mods
weight reduction
exercise
medication for glycemic control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mainstay tx for T2DM?

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hgb AIC goal for T2DM?

A

FBG 80-130 mg/dL

PP glucose (90-120 min)<180 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

for TIIDM, it is more important to treat what to decrease CV risk than to attain tight glycemic control?

A

HTN and hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

secondary agents for TIIDM?

short acting?
long acting?

A

GLP-1, SGLT-2, DPP-4, thiazolidinediones

sulfonylureas, both short and long acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

complications of diabetes and tx for DM?

A

weight gain(insulin, sulfonylureas, thiasolidinediones), weight loss (metformin, GLP-1 RA, SGLT-2 inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

initial therapy of HFeEF?

A

diuretic
angiotensin system blocker
-angiotensin receptor neprilysin inhibitor (sacubitril/valsartan)
-ace inhibitors
-angiotensin receptor blockers (valsartan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

secondary therapy of HFrEF?

A
mineralocorticoid receptor antagonist
SGLT2 inhibitor
ivabradine
hydralazine + nitrate
digoxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

for patients with HFpEF, improved outcome with what drugs?

A

sacubitril/valsartan

empagliflozin, SGLT-2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

for patients with HFpEF, improved outcome with what drugs?

A

sacubitril/valsartan

empagliflozin, SGLT-2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly